SOLACI

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Dr. Juan Manuel Pérez - 16 June, 2026 0

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Dr. Omar Tupayachi - 12 June, 2026 0

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Dr. Juan Manuel Pérez - 10 June, 2026 0

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy

A moderate dose of midazolam and fentanyl is effective in reducing radial spasms

Last News

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Institutional News

V International Course on Cardiovascular Interventionism – SOLACI Scientific Endorsement

Guatemala Sessions 2026 – Young Interventional Cardiologists Contest – Submit Your Case

Watch Again: Clinical Implications of Structural Heart Interventions — TAVI and MitraClip in Daily Practice

Access